FEB - 7 2005
CoolTouch Corporation
Model CT3S Nd:YAG Laser System
§10(k) Premarket Notification
510(k) SUMMARY Kr OX3 o%b
Submitter: Coo!Touch Corporation
Address: 9085 Foothills Boulevard
Roseville, CA 95747
Contact Person: Donald V. Johnson
Vice-President of Operations
Telephone: (916) 677-1912
Facsimile: (916) 677-1901
Date Prepared:
Device Trade Name: CoolTouch Corporation Model CT3S Nd:YAG Laser
System
Common Name: Nd: YAG Surgical Laser
Classification Name: Laser Surgical Instrument.
21 C.F.R. § 878.4810
Legally Marketed Predicate Device: | CoolTouch Corporation Model NS-160, CTEV.
Description of the CoolTouch The CoolTouch Nd:YAG Laser Systems are Nd:YAG
Nd:YAG Laser Systems: lasers producing laser emission at 1320 nm. The lasers
consist of three interconnected sections: The cabinet,
which houses the power supply, cooling system,
microcontroiler and the laser, the fiber optic, and/or the
handpiece.
Intended use of CoolTouch The intended use of the CoolTouch CT3S Nd:YAG
Nd:YAG Laser Systems: Laser System is:
a) for use in dermatology for incision, excision, ablation
and vaporization with hemostasis of soft tissue,
b) for treatment of fine lines and wrinkles,
c) for treatment of back acne and atrophic acne scars,
d) for treatment of reflux of the greater saphenous vein
associated with varicose veins and varicosities.
G2U

Nonclinical Performance Data: None
Clinical Performance Data: Clinical trials also produced results that indicated that
the CoolTouch Nd:YAG Laser Systems are effective in
the treatment of reflux of the greater saphenous vein
associated with varicose veins and varicosities. Sce
previous related 510(k) submissions for clinical results.
Conclusion: The Coo!Touch CT3S Nd:YAG Laser System is
indicated: .
a) for use in dermatology for incision, excision, ablation
and vaporization with hemostasis of soft tissue,
b) for the treatment of fine lines and wrinkles,
c) for treatment of back acne and atrophic acne scars,
d) for treatment of reflux of the greater saphenous vein
associated with varicose veins and varicosities.
Additional Information: None requested at this time
021

sm
f Y DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
Qo
* Food and Drug Administration
9200 Corporate Boulevard
FEB ~] 2005 Rockville MD 20850
Mr. Donald V. Johnson
Vice President of Operations
CoolTouch Corporation
9085 Foothills Boulevard
Roseville, California 95747
Re: K043046
Trade/Device Name: CoolTouch CT3S Nd:YAG Laser System
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: Il
Product Code: GEX
Dated: January 21, 2005
Received: January 24, 2005
Dear Mr. Johnson:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (sec above) into either class II (Special Controls) or class 11 (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as scl
forth in the quality systems (QS) regulation (21 CER Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Mr. Donald V. Johnson

This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.

‘ If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address hitp://Awww.fda.gov/cdrh/industry/support/index. html.

Sincerely yours,
by Manan 6
Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure

INDICATION FOR USE STATEMENT
510(k) Number: _ ko YZ otb
Device Name: CoolTouch CT3S Nd:YAG Laser System
Indications for Use:
The CoolTouch CT3S Nd:YAG Laser System is indicated:
a) for use in dermatology for incision, excision, ablation and vaporization with
hemostasis of soft tissue,
b) for use in the treatment of fine lines and wrinkles,
c) for treatment of back acne and atrophic acne scars,
d) for treatment of reflux of the greater saphenous vein associated with varicose
: veins and varicosities.
(Please do not write below this line - Continue on another page if needed)
a
Concurrence of CDRH, Office of Device Evaluation (ODE)
Murua C0. Paral
(Division Sign-Off)
Division of General, Restorative,
So Neurological Devices
Prescription Use__ OR K 0 4 58,48 .o-counter Use
510(k) Nuntbre?! CF 801.10) :
G23

